300347 泰格醫藥
按盤價 
53.090 +3.360 (+6.756%)
53.090 +3.360 (+6.756%) | 2023/12 - 人民幣(K¥) | 變動 | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | 2019/12 人民幣(K¥) | 2018/12 人民幣(K¥) | ||
| 營業總收入 | 7,384,039 | 4.21% | 5,213,538 | 3,192,279 | 2,803,309 | 2,300,660 | |
| 減：營業總成本 | 5,554,125 | 7.71% | 3,637,765 | 2,420,862 | 2,075,730 | 1,782,269 | |
| 其中:營業成本 | 4,535,511 | 6.04% | 2,942,883 | 1,678,036 | 1,500,406 | 1,308,913 | |
| 財務費用 | (108,324) | -31.49% | (216,363) | 88,052 | 9,558 | 7,393 | |
| 資產減值損失 | (29,725) | 1,130.46% | (12,915) | 5,414 | -- | (50,963) | |
| 公允價值變動收益 | 352,771 | -34.17% | 1,815,390 | 1,137,889 | 184,996 | 5,154 | |
| 投資收益 | 338,175 | 229.12% | 312,283 | 283,773 | 179,828 | 118,854 | |
| 其中：對聯營企業和合營企業的投資收益 | 105,183 | 164.53% | 14,348 | (3,508) | (9,768) | 9,598 | |
| 營業利潤 | 2,486,941 | -3.70% | 3,696,967 | 2,222,312 | 1,084,647 | 595,851 | |
| 利潤總額 | 2,488,533 | -3.75% | 3,684,566 | 2,218,707 | 1,089,162 | 606,072 | |
| 減：所得稅費用 | 338,606 | 7.96% | 292,864 | 189,707 | 113,839 | 99,275 | |
| 淨利潤 | 2,149,927 | -5.36% | 3,391,702 | 2,029,001 | 975,322 | 506,797 | |
| 減：非控股權益 | 125,077 | -52.83% | 517,539 | 279,226 | 133,688 | 34,613 | |
| 股東淨利潤 | 2,024,850 | 0.91% | 2,874,163 | 1,749,775 | 841,635 | 472,184 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 2.340 | 0.86% | 3.310 | 2.200 | 1.130 | 0.630 | |
| 每股派息 (元) * | 0.568 | 3.27% | 0.500 | 0.300 | 0.278 | 0.350 | |
| 每股淨資產 (元) * | 24.102 | 7.37% | 20.774 | 18.474 | 5.638 | 5.335 | |
| 審計意見 # | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 23/04/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
